| Literature DB >> 21243402 |
Yakini Brandy1, Innocent Ononiwu, Dolapo Adedeji, Vonetta Williams, Claudia Mouamba, Yasmine Kanaan, Robert L Copeland, Dwayne A Wright, Ray J Butcher, Samuel R Denmeade, Oladapo Bakare.
Abstract
The synthesis of five 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives was accomplished by refluxing 2-amino-3-bromo-1,4-naphthoquinone with appropriate benzoyl chloride analogs at elevated temperatures. In vitro anticancer evaluation of these compounds was performed on androgen-dependent, LNCaP, and androgen-independent, PC3, human prostate cancer cell lines. In general, these compounds displayed slightly stronger cytotoxicity on the androgen-dependent LNCaP than on the androgen-independent PC3 prostate cancer cell lines. The meta-substituted 2-(3-Chloro-phenyl)-naphtho[2,3-d]oxazole-4,9-dione (10) appear to display the best cytotoxicity on both cell lines with an IC(50) of 0.03 μM on LNCaP and 0.08 μM on PC3 after 5 days of exposure.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21243402 PMCID: PMC3756683 DOI: 10.1007/s10637-011-9635-3
Source DB: PubMed Journal: Invest New Drugs ISSN: 0167-6997 Impact factor: 3.850